HIV, HTLV-1/-2, and HCV share routes of transmission, and such virus co-infections could
account for worse outcomes of associated diseases. Measuring cytokines/chemokines, CD4 …

During the early 1980s, the first 3 human retroviruses were identified: human T-lymphotropic
virus 1 and 2 (HTLV-1 and HTLV-2) and human immunodeficiency virus (HIV). A person …

Several reports suggest that HTLV-I/HIV coinfection may be associated with an increased
risk of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). In HTLV-I …

Objectives: HIV, hepatitis C virus (HCV), and human T-cell lymphotropic virus type 1 (HTLV-
1) share the same routes of infection, making coinfection by these viruses a frequent finding …

Going back to their discovery in the early 1980s, both the Human T-cell Leukemia virus type-
1 (HTLV-1) and the Human Immunodeficiency Virus type-1 (HIV-1) greatly fascinated the …

Background. Human T cell lymphotropic virus type 2 (HTLV-2) infection is not rare among
injection drug users with human immunodeficiency virus (HIV) infection and may exert a …

Reports indicate that there is a dissociation between markers of HIV disease progression
and clinical stage among subjects coinfected with human T-cell lymphotropic virus type I …

Human T-lymphotropic virus type I (HTLV-I) and HTLV-II have been postulated to accelerate
disease progression in patients coinfected with HIV. However, recent evidence suggests that …

Co-infection with HTLV-1 reaches 20% among patients infected by HIV-1 in Bahia, Brazil. To
evaluate its impact on survival, we conducted a retrospective, case–control study involving …

Background HTLV-1 often infect HIV-HCV coinfected patients. The immunological
consequences of triple infection are still unclear. Objective: to compare the plasma levels of …